TEIJIN LIMITED (3401)

Market cap
¥304.2B
P/E ratio
-29.6x
Teijin develops and manufactures high-performance materials, fibers, and healthcare products including aramid fibers, pharmaceuticals, and medical devices.
Period EndRevenue growth (%) YoY (%)
Mar 31, 20251.6+18.84%
Mar 31, 20241.4-86.21%
Mar 31, 202310-6.45%
Mar 31, 202210.7-629.70%
Mar 31, 2021-2-48.47%
Mar 31, 2020-3.9-161.06%
Mar 31, 20196.4-49.21%
Mar 31, 201812.6-302.24%
Mar 31, 2017-6.2-1177.59%
Mar 31, 20160.6+163.64%
Mar 31, 20150.2-95.76%
Mar 31, 20145.2-140.80%
Mar 31, 2013-12.7
AI Chat